2022
DOI: 10.18632/oncotarget.28168
|View full text |Cite
|
Sign up to set email alerts
|

Induction of serine hydroxymethyltransferase 2 promotes tumorigenesis and metastasis in neuroblastoma

Abstract: High-risk neuroblastoma (NB) remains an extremely difficult subgroup to cure and is associated with MYCN amplification. Serine hydroxymethyltransferase 2 (SHMT2) regulates serine metabolism in a myc-dependent manner; it is upregulated in several cancers and is associated with tumor aggressiveness. Akt-2, an important regulator of MYCN via the PI3K/Akt pathway, induces metastatic potential in NB. The association between SHMT2 and PI3K/Akt in hepatocyte regeneration … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
6
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 7 publications
(7 citation statements)
references
References 23 publications
0
6
0
Order By: Relevance
“…The 1 H NMR matches the 1 H NMR reported in the literature. 75 Methyl 4-((3-Iodopropyl)thio)benzoate (23). Compound 23 was prepared using the general method described for the preparation of 19a−b, 23, and 31e, from compound 22 (2.5 g, 10.40 mmol), methanesulfonyl chloride (1 mL, 13.02 mmol), and triethylamine (1.60 mL, 11.44 mmol) to form the intermediate.…”
Section: ■ Conclusionmentioning
confidence: 99%
See 1 more Smart Citation
“…The 1 H NMR matches the 1 H NMR reported in the literature. 75 Methyl 4-((3-Iodopropyl)thio)benzoate (23). Compound 23 was prepared using the general method described for the preparation of 19a−b, 23, and 31e, from compound 22 (2.5 g, 10.40 mmol), methanesulfonyl chloride (1 mL, 13.02 mmol), and triethylamine (1.60 mL, 11.44 mmol) to form the intermediate.…”
Section: ■ Conclusionmentioning
confidence: 99%
“…Importantly, serine catabolism is frequently upregulated in cancer, with SHMT2 and MTHFD2 among the most overexpressed metabolic genes in human cancers compared to normal tissues . Indeed, studies in several cancers suggest that SHMT2 is a bona fide “onco-driver”. Further, overexpression of SHMT2 is associated with poor prognosis in breast cancer, lung adenocarcinoma, pancreatic cancer, gliomas, and gastrointestinal cancers . In invasive breast cancer, adrenal carcinoma, and renal cell carcinomas, SHMT2 is likewise overexpressed .…”
Section: Introductionmentioning
confidence: 99%
“…Cells were collected using cell lysis buffer and denatured samples were prepared for immunoblotting, as we have previously described [23,24]. Equal amounts of protein were loaded and separated by NuPAGE 4-12% Bis-Tris gel, followed by transfer onto PVDF membranes (Bio-Rad, Hercules, CA, USA).…”
Section: Immunoblottingmentioning
confidence: 99%
“…Serine hydroxymethyltransferase (SHMT) 2 (Uniprot entry Q150818) is a 5′-pyridoxal phosphate (PLP)-associated enzyme that catalyzes the conversion of serine to glycine in mitochondria, resulting in generation of 5,10-methylene tetrahydrofolate (mTHF) from THF (Figure ). SHMT2 is among the most overexpressed metabolic enzymes in a variety of cancers, and SHMT2 expression is widely associated with tumor progression and patient prognosis (e.g., breast cancer, nonsmall lung cancer, pancreatic cancer). ,, SHMT2 generates ∼85% of cellular glycine required for synthesis of glutathione, purines, proteins, and porphyrins; the mitochondrial 1C pathway supplies the majority of 1C units (as formate) for cellular biosynthesis in the cytosol. , , Further, mitochondrial 1C metabolism from serine is also an important source of NAD­(P)H and generates ATP. , Finally, loss of SHMT2 results in defective mitochondrial respiration due to impaired synthesis of respiratory chain proteins. , …”
Section: Introductionmentioning
confidence: 99%